Bio-Pharma Developments in IPRs: Hedge Fund Managers, Biologics, and Small Molecules
Join the Federal Bar Association’s University of Minnesota Law School Student Division for its "Bio-Pharma Developments in IPRs: Hedge Fund Managers, Biologics, and Small Molecules” program on March 23, 2016. Fish & Richardson attorneys Tasha Francis, Ph. D. and Joseph Herriges will speak about upcoming issues related to the intersection of biosimilars and small molecules and inter partes review. Lunch will be provided.
CLE Credits
1 Standard CLE credit has been approved; Event Code #217507